GrowthWorks

GrowthWorks is a Canadian asset management firm established in 1992, specializing in the management of regionally based venture capital funds. Headquartered in Vancouver, GrowthWorks focuses on early-stage investments primarily in the cleantech, healthcare, and technology sectors. The firm manages several retail venture capital funds, including the Working Opportunity Fund and the GrowthWorks Commercialization Fund, aiming to support growth-oriented companies across Canada. GrowthWorks employs specialized teams to identify and structure investments, providing strategic management support to help portfolio companies succeed. This approach not only enhances the potential for returns on investments but also fosters vital industry connections and minimizes risk through diversification. Over its history, GrowthWorks has made numerous investments, demonstrating a commitment to driving growth in emerging businesses while ensuring accountability and experienced guidance for its investors.

Peter Damianov

Investor

Zahra Mamdani

Investor

Steve Stang

Investor

Past deals in British Columbia

HIGHLINEvc

Pre Seed Round in 2016
HIGHLINE is a Pre-Seed investor & Acceleration Platform that helps digital startups get follow-on capital, backed by leading VCs with offices in Vancouver & Toronto. We believe in providing our founders with far more than capital. Yet unlike most accelerators, we have no rigid start/end dates throughout the year. By joining the HIGHLINE family, you get to call on us for advice on an ongoing basis, gain access to our premium network and monthly founder events. We’ll do our best to help with fundraising challenges and partner with incubators to help deliver specialized programming. [Growlab Ventures](https://www.crunchbase.com/organization/growlab-ventures) and [Extreme Startups](https://www.crunchbase.com/organization/extreme-startups) have merged to create HIGHLINEvc as of August 2014.

Switch Materials

Series C in 2015
SWITCH Materials Inc. designs smart window solutions for automotive applications for OEMs and Tier 1 suppliers. It serves lower emissions, electric vehicles, customer impact, and custom solar management applications. The company was founded in 2007 and is based in Burnaby, Canada.

General Fusion

Venture Round in 2015
General Fusion Inc. is focused on developing commercial Magnetized Target Fusion (MTF), a hybrid approach that combines elements of magnetic fusion and inertial confinement fusion to create clean and abundant energy. Founded in 2002 and headquartered in Burnaby, Canada, the company aims to demonstrate and commercialize its innovative fusion technology by the end of the decade. General Fusion's approach leverages recent advancements in MTF, which has been underexplored since the 1970s, positioning it as a practical solution for near-term fusion energy. The company is developing utility-scale fusion power systems and various subsystems, including plasma injectors and acoustic drivers, to support its vision. With backing from a global network of energy venture capital funds and industry leaders, General Fusion seeks to reduce technical risks and accelerate the path toward viable fusion energy solutions.

BuildDirect

Series C in 2014
BuildDirect Technologies Inc. operates an online marketplace specializing in home improvement products, directly connecting consumers and contractors with suppliers and manufacturers. Founded in 1999 and headquartered in Vancouver, Canada, the company offers a diverse range of product categories including flooring, decking, building materials, kitchen and bath items, and doors. BuildDirect is recognized for creating the first open network for heavyweight goods and launched the BuildDirect Home Marketplace, which is the largest online platform for these products, enabling suppliers to manage their sales and distribution effectively. In 2017, the company expanded its services by introducing the Gateway Supply Chain, which allows third parties to access its logistics network, including warehousing and transportation services, enhancing the efficiency of product delivery from manufacturing to end consumers. With warehouses located across North America, BuildDirect continues to innovate in the home improvement sector.

Cooledge

Venture Round in 2014
Cooledge Lighting is a venture backed start-up focused on delivering high value solid-state lighting solutions to the general illumination market. Founded in 2009, Cooledge is currently in the development stage of the company with product launch coming at Lightfair 2013 in Philadelphia, PA.

ResponseTek

Venture Round in 2014
ResponseTek Networks Corp. specializes in customer experience management software, offering the ResponseTek Listening Platform, which delivers comprehensive insights and analytics to organizations. This platform facilitates multi-channel customer feedback collection through various methods, including SMS surveys and social media monitoring, enabling businesses to gain a unified view of their customer interactions. It provides tools for role-based reporting, real-time data integration, and program management, enhancing the ability of companies to respond effectively to customer needs. Serving sectors such as telecommunications, finance, healthcare, and retail, ResponseTek has established partnerships with major firms like Nielsen and IBM. Founded in 1999 and headquartered in Vancouver, Canada, the company has expanded its presence with offices in North America, Europe, India, and Australia, catering to a global clientele that includes notable corporations like HSBC and Vodafone.

INETCO

Venture Round in 2013
INETCO® builds smart technology that increases the reliability, safety and value of every digital and self-service payment. Our real-time transaction monitoring and analytics platform, INETCO Insight, has been selected by leading banks, payment service providers and retailers – in over 35 countries - to accelerate their digital transformation strategies and to speed up the detection of payment fraud and performance issues threatening to impact revenue, reputation and the end customer experience.

MSI Methylation Sciences

Series A in 2011
MSI Methylation Sciences Inc. is a biotechnology company based in Canada that focuses on developing oral and small molecule therapies for the adjunctive treatment of Major Depressive Disorder (MDD). Founded in 2007, the company is known for its flagship product, Strada, which is an orally administered therapy aimed at alleviating symptoms of depression in MDD patients. In addition to its therapeutic developments, MSI Methylation Sciences also markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. The company's work is centered around addressing mental health challenges through innovative treatment options.

General Fusion

Series B in 2011
General Fusion Inc. is focused on developing commercial Magnetized Target Fusion (MTF), a hybrid approach that combines elements of magnetic fusion and inertial confinement fusion to create clean and abundant energy. Founded in 2002 and headquartered in Burnaby, Canada, the company aims to demonstrate and commercialize its innovative fusion technology by the end of the decade. General Fusion's approach leverages recent advancements in MTF, which has been underexplored since the 1970s, positioning it as a practical solution for near-term fusion energy. The company is developing utility-scale fusion power systems and various subsystems, including plasma injectors and acoustic drivers, to support its vision. With backing from a global network of energy venture capital funds and industry leaders, General Fusion seeks to reduce technical risks and accelerate the path toward viable fusion energy solutions.

Boreal Genomics

Series B in 2010
Boreal Genomics Inc. is a biotechnology company that focuses on the development and commercialization of technologies for blood-based detection and monitoring of circulating tumor DNA. Founded in 2007 and headquartered in Los Altos, California, with an additional office in Vancouver, Canada, the company offers products like OnTarget, which allows for the sensitive detection and quantification of tumor mutations in plasma or tissue. Boreal's platform is designed to enable healthcare professionals to perform accurate genomic profiling and monitor tumor evolution from cell-free DNA in plasma, thereby improving cancer patient care. The OnTarget assay, available as a research-use service, reveals tumor mutations that may be undetectable by other methods, assisting in therapy selection, enhancing clinical trial efficiency, and expediting drug development. Additionally, Boreal provides DNA enrichment and library construction solutions tailored for high accuracy sequencing in liquid biopsy applications.

Copperleaf

Series A in 2010
Copperleaf Technologies Inc. is a provider of enterprise software solutions designed for asset-intensive organizations dealing with aging infrastructure challenges in Canada and internationally. The company specializes in decision analytics that leverage operational and financial data, enabling clients to optimize capital planning, asset life cycle management, and budgeting. Its flagship product, Copperleaf C55, supports asset investment planning and management by helping organizations make risk-informed decisions, forecast performance, and evaluate investment options with real data. Additionally, Copperleaf offers Copperleaf ESP, a solution for utilities to design and manage demand-side management projects effectively. The company serves sectors such as electrical power generation, transmission, distribution, and gas and water utilities. Founded in 2000 and headquartered in Burnaby, Canada, Copperleaf collaborates with a network of expert partners to deliver its solutions globally.

Redlen Technologies

Venture Round in 2010
Redlen Technologies Inc. specializes in the manufacture of cadmium zinc telluride (CZT) semiconductors, which are essential for radiation detection and imaging equipment used in medical and security applications. Founded in 1999 and headquartered in Saanichton, Canada, the company produces high-resolution CZT detectors that enhance the performance of technologies such as nuclear cardiology, CT scanning, baggage scanning, and bomb detection. Redlen has pioneered a unique production process known as the Traveling Heater Method (THM), which improves the cost-effectiveness and availability of CZT materials, facilitating broader adoption in the medical and security sectors. Additionally, the company provides advanced thin film solar cadmium telluride feedstock solutions, contributing to the thin-film solar photovoltaic market. With a strong focus on innovation and quality, Redlen Technologies is positioned to significantly impact the landscape of radiation-based imaging technologies.

Vitrium

Venture Round in 2010
Vitrium Systems Inc. provides document security and digital rights management (DRM) software for PDF, office and OpenOffice files, TXT files, and images. Its software enables creators, publishers, and distributors of content to control and protect documents and images. Its solutions include document security, enterprise DRM, secure file sharing, image protection, tracking and analytics, and central user portal. It offers consulting, implementation, integration, and support services. It serves education and training, research and advisory, associations, financial services, media and publishing, and technology industries. The company was founded in 2005 and is based in Vancouver, Canada.

Switch Materials

Series B in 2010
SWITCH Materials Inc. designs smart window solutions for automotive applications for OEMs and Tier 1 suppliers. It serves lower emissions, electric vehicles, customer impact, and custom solar management applications. The company was founded in 2007 and is based in Burnaby, Canada.

Strutta

Debt Financing in 2009
Strutta is a technology company based in Vancouver, BC, that specializes in social media promotion services. It provides do-it-yourself tools that enable brands, agencies, and developers to create and manage interactive contests and sweepstakes. Strutta's platform connects brands with their target consumers, allowing them to design and execute tailored social-promotion campaigns aimed at driving leads, awareness, and sales. The company has successfully powered award-winning promotions for a wide range of clients, including notable brands such as Microsoft, AirBNB, and Coca-Cola, among others. As a Facebook Preferred Marketing Developer, Strutta continues to enhance its offerings to meet the evolving needs of its diverse clientele.

General Fusion

Series A in 2009
General Fusion Inc. is focused on developing commercial Magnetized Target Fusion (MTF), a hybrid approach that combines elements of magnetic fusion and inertial confinement fusion to create clean and abundant energy. Founded in 2002 and headquartered in Burnaby, Canada, the company aims to demonstrate and commercialize its innovative fusion technology by the end of the decade. General Fusion's approach leverages recent advancements in MTF, which has been underexplored since the 1970s, positioning it as a practical solution for near-term fusion energy. The company is developing utility-scale fusion power systems and various subsystems, including plasma injectors and acoustic drivers, to support its vision. With backing from a global network of energy venture capital funds and industry leaders, General Fusion seeks to reduce technical risks and accelerate the path toward viable fusion energy solutions.

Teradici

Series C in 2009
Teradici Corporation specializes in PC-over-IP (PCoIP) technology, which facilitates the transfer of images from centralized servers or workstations to various PCoIP-ready endpoints. This technology enhances the provisioning and management of computing services, supporting diverse work styles including remote, mobile, and collaborative environments. Teradici's offerings encompass a range of solutions such as zero clients, optimized thin clients, hardware accelerators, remote workstation cards, workstation access software, and a management console for enterprise deployment. These products cater to industries like education, financial services, healthcare, media and entertainment, and architecture, among others. The company also provides cloud solutions, desktop virtualization infrastructure, and support services. Teradici's clientele includes Fortune 500 companies, government agencies, and cloud service providers, and it collaborates with OEM partners globally. Founded in 2004 and headquartered in Burnaby, Canada, Teradici is committed to innovation and has secured over 40 patents in its field.

Layer 7 Technologies

Venture Round in 2009
Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

Bootup Labs

Seed Round in 2008
Bootup Labs was a startup accelerator and incubator based in Vancouver, Canada, founded in 2008. The organization specialized in supporting early-stage digital media companies by recruiting promising entrepreneurs and providing them with mentorship, ongoing support, and office space. Bootup Labs aimed to help these companies develop their business models and secure venture financing, ultimately assisting eight companies in becoming "fundable." Through its resources and guidance, Bootup Labs fostered innovation and growth within the local startup ecosystem.

Sutus

Venture Round in 2008
Sutus specializes in providing integrated communication and IT services tailored for small businesses with 3 to 25 employees. The company offers a comprehensive software platform called Sutus Business Central, which includes tools for networking, data management, telephone services, security, and collaboration. Sutus supports various operating systems, including Windows, Mac, and Linux, and ensures compatibility with popular applications such as Microsoft Outlook, Entourage, and Apple Mail. Their services encompass network infrastructure, file and data sharing, collaboration tools, and fully integrated telephone handsets, enabling small businesses to enhance their operational efficiency and communication capabilities.

Inimex Pharmaceuticals

Series B in 2008
Inimex Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of Innate Defense Regulators (IDRs). These innovative drugs are designed to selectively modulate the body's innate immune defenses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, reduce tissue damage, and mitigate bacterial infections. Inimex's IDR products target a range of medical conditions, including infections and tissue injury-related ailments such as ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is dedicated to advancing its unique therapies to improve patient outcomes.

Strutta

Seed Round in 2008
Strutta is a technology company based in Vancouver, BC, that specializes in social media promotion services. It provides do-it-yourself tools that enable brands, agencies, and developers to create and manage interactive contests and sweepstakes. Strutta's platform connects brands with their target consumers, allowing them to design and execute tailored social-promotion campaigns aimed at driving leads, awareness, and sales. The company has successfully powered award-winning promotions for a wide range of clients, including notable brands such as Microsoft, AirBNB, and Coca-Cola, among others. As a Facebook Preferred Marketing Developer, Strutta continues to enhance its offerings to meet the evolving needs of its diverse clientele.

CellFor

Venture Round in 2007
CellFor is the world's leading independent supplier of high technology seedlings to the global forest industry. Using plant biotechnology, which is the use of biological processes to manufacture products, CellFor identifies and produces genetically superior conifer seedlings without genetic modification.

Neuromed Pharmaceuticals

Series E in 2007
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Paymentus

Venture Round in 2007
Paymentus Corporation is a provider of electronic billing and payment solutions in North America, specializing in a SaaS-based platform that facilitates direct-bill organizations in offering a range of payment options. These include mobile payments, online quick pay, pay-by-text, interactive voice response, autopay, and self-service portals. The company also emphasizes paperless eBilling and customer communication. Founded in 2004 and headquartered in Charlotte, North Carolina, Paymentus has additional offices across multiple cities, including Atlanta and Vancouver. It serves various industries such as auto finance, healthcare, utilities, insurance, and financial services, delivering solutions for revenue management, customer self-service, and electronic bill presentment. The company's offerings are designed to enhance customer engagement and streamline payment processes while ensuring compliance with industry standards.

Switch Materials

Venture Round in 2007
SWITCH Materials Inc. designs smart window solutions for automotive applications for OEMs and Tier 1 suppliers. It serves lower emissions, electric vehicles, customer impact, and custom solar management applications. The company was founded in 2007 and is based in Burnaby, Canada.

Brownbag

Series A in 2007
Brownbag operates as a customer-focused platform that enables users to discover a wide array of products and services tailored to their daily needs. It emphasizes a comprehensive selection, competitive pricing, efficient delivery, and stringent quality control to enhance the user experience. In addition to catering to consumers, Brownbag offers a robust e-commerce platform for sellers, facilitating their access to a broader market. The company also plays a significant role in the crowdsourcing news landscape, connecting ordinary citizens and citizen journalists with major news networks, thereby allowing them to share stories and insights on various topics, including politics, culture, and entertainment. This dual approach not only satisfies consumer demands but also enriches the news ecosystem by amplifying diverse voices.

Protiva Biotherapeutics

Venture Round in 2007
Protiva Biotherapeutics, Inc., a development stage biotechnology company, develops nucleic acid based pharmaceutical products. The company focuses on developing products to fight various human diseases, such as cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. Its products include Pro 1, a tumor cell growth inhibitor, which kills tumor cells and inhibits tumor growth; Pro-101, an siRNA product that acts to inhibit the production of a protein involved in tumor growth; Pro-B, which acts to inhibit the expression of a protein, apolipoprotein B; Pro-EBOV and Pro-MARV that act to inhibit the replication of the Ebola and Marburg viruses; and Stable Nucleic-Acid Lipid Particle technology, an encapsulation and delivery system for nucleic acid payloads, such as short interfering RNA (siRNA), to target cells. The company also develops Hepatitis siRNA products for the treatment of hepatitis B and C. Protiva Biotherapeutics, Inc. has a research and development facility in Vancouver, Canada. The company was founded in 2000 and is based in Seattle, Washington. As of May 30, 2008, Protiva Biotherapeutics, Inc. operates as a subsidiary of Tekmira Pharmaceuticals Corp.

Brownbag

Series A in 2007
Brownbag operates as a customer-focused platform that enables users to discover a wide array of products and services tailored to their daily needs. It emphasizes a comprehensive selection, competitive pricing, efficient delivery, and stringent quality control to enhance the user experience. In addition to catering to consumers, Brownbag offers a robust e-commerce platform for sellers, facilitating their access to a broader market. The company also plays a significant role in the crowdsourcing news landscape, connecting ordinary citizens and citizen journalists with major news networks, thereby allowing them to share stories and insights on various topics, including politics, culture, and entertainment. This dual approach not only satisfies consumer demands but also enriches the news ecosystem by amplifying diverse voices.

EQO

Series B in 2007
Like most other players in this space, EQO helps save you money on long distance calls by bridging long distance calls over cheaper IP lines. What essentially happens is that your phone an EQO server on a local number, which transfers your call onto cheaper data lines across the internet, and then hops back onto standard phone lines and through another local number to the callee. The call only costs you minutes from your phone plan and the data cost for the VOIP line which runs 95-98% less than standard calling rates. Callers will store value for phone calls in EQO credits. However, calling another EQO user is free.

Layer 7 Technologies

Series B in 2006
Layer 7 Technologies provides security and management products for API-driven integrations spanning the extended hybrid enterprise. It offers API management solutions such as API Proxy, a virtual API gateway that gives API publishers a tool for securing, orchestrating, and optimizing APIs as well as enforcing SLAs; XML Firewall that is designed to address access, federation, and message security needs in service oriented architecture (SOA) based integrations; SOA Gateway, an API Gateway that provides data translation, contextual routing, SLA management, caching, protocol switching, and B2B functionality; and Mobile Access Gateway, which simplifies the process of adapting internal data, application, and security infrastructure for mobile use. The company also offers developer management solutions, including API Portal, a platform for developer onboarding, engagement, and management; and operations management solutions such as API Service Manager that simplifies API, service, and gateway management across datacenters and the cloud. In addition, it offers identity management solutions, including OAuth Toolkit which empowers users to control access to their APIs; and Security Token Service for API identity translation and federation. Further, the company offers API academy training in the areas of introduction, API design and architecture, API strategy consulting, and hackathon management; IT services, such as architectural consulting, implementation, and operational health check; and gateway, API portal, and administrator training services. The company was founded in 2003 and is based in Vancouver, Canada. Currently, it operates as a subsidiary of CA Technologies.

CellFor

Venture Round in 2006
CellFor is the world's leading independent supplier of high technology seedlings to the global forest industry. Using plant biotechnology, which is the use of biological processes to manufacture products, CellFor identifies and produces genetically superior conifer seedlings without genetic modification.

Protiva Biotherapeutics

Series C in 2006
Protiva Biotherapeutics, Inc., a development stage biotechnology company, develops nucleic acid based pharmaceutical products. The company focuses on developing products to fight various human diseases, such as cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. Its products include Pro 1, a tumor cell growth inhibitor, which kills tumor cells and inhibits tumor growth; Pro-101, an siRNA product that acts to inhibit the production of a protein involved in tumor growth; Pro-B, which acts to inhibit the expression of a protein, apolipoprotein B; Pro-EBOV and Pro-MARV that act to inhibit the replication of the Ebola and Marburg viruses; and Stable Nucleic-Acid Lipid Particle technology, an encapsulation and delivery system for nucleic acid payloads, such as short interfering RNA (siRNA), to target cells. The company also develops Hepatitis siRNA products for the treatment of hepatitis B and C. Protiva Biotherapeutics, Inc. has a research and development facility in Vancouver, Canada. The company was founded in 2000 and is based in Seattle, Washington. As of May 30, 2008, Protiva Biotherapeutics, Inc. operates as a subsidiary of Tekmira Pharmaceuticals Corp.

Neuromed Pharmaceuticals

Series D in 2006
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Marqui

Series B in 2006
Marqui is a cloud-based platform designed for marketing teams to efficiently create, update, and manage website content without requiring coding skills. The platform facilitates the production and publication of web-ready HTML, CSS, and Javascript content, enabling users to control content creation, scheduling, and publication from a single interface. Marqui enhances user experience through its streamlined workflow controls, ensuring an intuitive and organized approach to content management. Additionally, the company offers in-house services to assist teams in designing and developing websites and marketing campaigns. Their Client Success Team provides real-time support to address inquiries and maintain smooth day-to-day operations, further enhancing the overall user experience.
QuIC Financial Technologies, Inc. specializes in developing advanced simulation, risk calculation, and pricing platform solutions for financial institutions and companies. The company's product suite includes the QuIC Engine, a high-performance calculator designed for desktop computers, and QuIC Script, a vector computing language that facilitates the expression of financial solutions. QuIC Analytics offers a range of instruments, encompassing interest rate and foreign exchange derivatives, equities, commodities, hybrids, asset-backed securities, and credit derivatives. Additionally, QuIC provides tools such as QuIC Workbench for the development and testing of QuIC Script, as well as the QuIC Simulation Framework, which supports enterprise-scale portfolio simulation workflows. Integration offerings include QuIC Dispatch for interfacing with client solutions and QuIC Bridge for connecting QuIC Script

EQO

Series A in 2006
Like most other players in this space, EQO helps save you money on long distance calls by bridging long distance calls over cheaper IP lines. What essentially happens is that your phone an EQO server on a local number, which transfers your call onto cheaper data lines across the internet, and then hops back onto standard phone lines and through another local number to the callee. The call only costs you minutes from your phone plan and the data cost for the VOIP line which runs 95-98% less than standard calling rates. Callers will store value for phone calls in EQO credits. However, calling another EQO user is free.

CellFor

Series C in 2005
CellFor is the world's leading independent supplier of high technology seedlings to the global forest industry. Using plant biotechnology, which is the use of biological processes to manufacture products, CellFor identifies and produces genetically superior conifer seedlings without genetic modification.

Teradici

Venture Round in 2004
Teradici Corporation specializes in PC-over-IP (PCoIP) technology, which facilitates the transfer of images from centralized servers or workstations to various PCoIP-ready endpoints. This technology enhances the provisioning and management of computing services, supporting diverse work styles including remote, mobile, and collaborative environments. Teradici's offerings encompass a range of solutions such as zero clients, optimized thin clients, hardware accelerators, remote workstation cards, workstation access software, and a management console for enterprise deployment. These products cater to industries like education, financial services, healthcare, media and entertainment, and architecture, among others. The company also provides cloud solutions, desktop virtualization infrastructure, and support services. Teradici's clientele includes Fortune 500 companies, government agencies, and cloud service providers, and it collaborates with OEM partners globally. Founded in 2004 and headquartered in Burnaby, Canada, Teradici is committed to innovation and has secured over 40 patents in its field.

Inimex Pharmaceuticals

Series A in 2004
Inimex Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of Innate Defense Regulators (IDRs). These innovative drugs are designed to selectively modulate the body's innate immune defenses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, reduce tissue damage, and mitigate bacterial infections. Inimex's IDR products target a range of medical conditions, including infections and tissue injury-related ailments such as ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is dedicated to advancing its unique therapies to improve patient outcomes.

Inimex Pharmaceuticals

Series A in 2004
Inimex Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, specializing in the development and commercialization of Innate Defense Regulators (IDRs). These innovative drugs are designed to selectively modulate the body's innate immune defenses without inducing inflammation. The company's lead product, IMX942, aims to enhance survival rates, reduce tissue damage, and mitigate bacterial infections. Inimex's IDR products target a range of medical conditions, including infections and tissue injury-related ailments such as ventilator-associated pneumonia, tracheobronchitis, bacteremia, endocarditis, mucositis, and certain cancers. Founded in 2001, Inimex Pharmaceuticals is dedicated to advancing its unique therapies to improve patient outcomes.

Neuromed Pharmaceuticals

Series C in 2003
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

TwinStrand Biosciences

Venture Round in 2003
Twinstrand Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of biological drugs for the treatment of life-threatening diseases. The product of the company is TST10088. It is a recombinant protein-based prodrug for activation by matrix metalloproteinases associated with solid tumor forms of cancer. Twinstrand is a Canada-based company that was founded in 1995. The company was acquired by Cangene on July 7, 2009.

Angstrom Power

Venture Round in 2002
Angstrom Power Incorporated researches and develops portable fuel cell devices. It provides Micro Hydrogen, an electrochemical energy converter that produces electricity, water vapor, and heat from hydrogen and airborne oxygen.

Colligo

Series A in 2002
Enterprise-strength email management and document management solutions for Microsoft SharePoint Colligo Networks is the leader in email and document management solutions for Microsoft SharePoint. Enterprises that use SharePoint rely on Colligo's award-winning solution suite to improve collaboration, increase productivity, and mitigate corporate risk. Featuring seamless integration with Microsoft Outlook and Windows Explorer, Colligo drives SharePoint adoption by making it easy to tag, find, store, and share SharePoint content in familiar ways, regardless of device, connectivity, or SharePoint location. Colligo's email and document management solutions for SharePoint are used by over 4800 organizations in 55 countries, with Global 500 customers including Microsoft, Kraft Foods, General Motors, and Siemens. Colligo Networks is a Microsoft Gold Certified Partner.

NxtPhase

Venture Round in 2001
NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.

Xenon Pharmaceuticals

Venture Round in 2001
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Burnaby, Canada, focused on developing innovative therapeutics for neurological disorders. The company's clinical pipeline includes several product candidates targeting epilepsy, such as XEN496 and XEN1101, both Kv7 potassium channel modulators currently in Phase II trials, and XEN901, a selective Nav1.6 sodium channel inhibitor in Phase I trials. Additionally, XEN007, a central nervous system-acting calcium channel modulator, is also in Phase I trials. Xenon utilizes a proprietary discovery platform, known as Extreme Genetics, to identify genetic insights from families with severe phenotypes, enabling the development of novel medicines for both orphan and more common diseases. The company has established a collaboration with Neurocrine Biosciences to advance first-in-class treatments for epilepsy, highlighting its commitment to addressing unmet medical needs in the field of neurology.

Neuromed Pharmaceuticals

Series B in 2001
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States. Neuromed Pharmaceuticals was acquired by Zalicus in December 2009. Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.

Chancery Software

Venture Round in 2000
Chancery Software is a prominent provider of student information management solutions tailored for K-12 schools and districts. The company offers a range of software tools that assist in managing critical aspects of student information, including enrollments, scheduling, attendance, grading, and performance analysis. Serving over thirteen million students and one million educators daily, Chancery's solutions are designed to address the specific challenges faced by educational institutions. With a commitment to compliance with reporting requirements such as the No Child Left Behind Act, Chancery has established itself as a reliable partner in the educational sector. With over 15 years of experience and 18,000 customized installations across North America, Chancery Software is recognized as a trusted resource for schools and districts of varying sizes and budgets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.